Addiction medicine science and practice /

por Johnson, Bankole A.
Publicado 2011

UPDATE ON NEUROPHARMACOLOGICAL TREATMENTS FOR ALCOHOLISM: SCIENTIFIC BASIS AND CLINICAL FINDINGS

por JOHNSON, BANKOLE A.
Publicado 2007

Naltrexone long-acting formulation in the treatment of alcohol dependence

por Johnson, Bankole A
Publicado 2007

MEDICATION TREATMENT OF DIFFERENT TYPES OF ALCOHOLISM

por Johnson, Bankole A.
Publicado 2010

Serotonin Transporter Genomic Biomarker for Quantitative Assessment of Ondansetron Treatment Response in Alcoholics

por Seneviratne, Chamindi, Johnson, Bankole A.
Publicado 2012

Advances in Medications and Tailoring Treatment for Alcohol Use Disorder

por Seneviratne, Chamindi, Johnson, Bankole A.
Publicado en Alcohol Res (2015)

TOPIRAMATE IN THE NEW GENERATION OF DRUGS: EFFICACY IN THE TREATMENT OF ALCOHOLIC PATIENTS

por Johnson, Bankole A., Ait-Daoud, Nassima
Publicado 2010

Medications To Treat Alcoholism

por Johnson, Bankole A., Ait-Daoud, Nassima
Publicado en Alcohol Res Health (1999)

Effect of topiramate treatment on ethanol consumption in rats

por Breslin, Florence J., Johnson, Bankole A., Lynch, Wendy J.
Publicado 2009

PREDICTION OF SEROTONERGIC TREATMENT EFFICACY USING AGE OF ONSET AND TYPE A/B TYPOLOGIES OF ALCOHOLISM

por Roache, John D., Wang, Yanmei, Ait-Daoud, Nassima, Johnson, Bankole A.
Publicado 2008

Obtaining the Optimal Dose in Alcohol Dependence Studies

por Wages, Nolan A., Liu, Lei, O’Quigley, John, Johnson, Bankole A.
Publicado 2012

Severity of drinking as a predictor of efficacy of the combination of ondansetron and topiramate in rat models of ethanol consumption and relapse

por Lynch, Wendy J., Bond, Colin, Breslin, Florence J., Johnson, Bankole A.
Publicado 2011

The efficacy of a low dose combination of topiramate and naltrexone on ethanol reinforcement and consumption in rat models

por Moore, Catherine F, Protzuk, Omar A, Johnson, Bankole A, Lynch, Wendy J
Publicado 2013

Characterization of a functional polymorphism in the 3’UTR of SLC6A4 and its association with drinking intensity

por Seneviratne, Chamindi, Huang, Weihua, Ait-Daoud, Nassima, Li, Ming D., Johnson, Bankole. A.
Publicado 2008

DETERMINATION OF GENOTYPE COMBINATIONS THAT CAN PREDICT THE OUTCOME OF THE TREATMENT OF ALCOHOL DEPENDENCE USING THE 5-HT(3) ANTAGONIST ONDANSETRON

por Johnson, Bankole A., Seneviratne, Chamindi, Wang, Xin-Qun, Ait-Daoud, Nassima, Li, Ming D.
Publicado 2013

Cumulative Proportion of Responders Analysis (CPRA) as a Tool to Assess Treatment Outcome in Alcohol Clinical Trials

por Falk, Daniel E, Litten, Raye Z, Anton, Raymond F, Kranzler, Henry R, Johnson, Bankole A
Publicado 2014

Acute and chronic administration of a low-dose combination of topiramate and ondansetron reduces ethanol’s reinforcing effects in male Alcohol Preferring (P) rats

por Moore, Catherine F, Lycas, Matthew D, Bond, Colin W, Johnson, Bankole A, Lynch, Wendy J
Publicado en Exp Clin Psychopharmacol (2014)

Susceptibility locus in neurokinin-1 receptor gene associated with alcohol dependence

por Seneviratne, Chamindi, Ait-Daoud, Nassima, Ma, Jennie Z., Chen, Guobo, Johnson, Bankole A., Li, Ming D.
Publicado 2009

Trajectory Analyses in Alcohol Treatment Research

por Chen, Jinsong, Johnson, Bankole A., Wang, Xin-Qun, O’Quigley, John, Isaac, Maria, Zhang, Daowen, Liu, Lei
Publicado 2012

Changes in Affect and Drinking Outcomes in a Pharmacobehavioral Trial for Alcohol Dependence

por Vaughan, Michelle D., Hook, Joshua N., Wagley, J. Nile, Davis, Don, Hill, Christina, Johnson, Bankole A., Penberthy, J. Kim
Publicado 2012